FDA Approves Unknown Drug — SAGENT PHARMS INC

# FDA Approves Generic Drug Application for Sagent Pharmaceuticals Sagent Pharmaceuticals Inc. received FDA approval for ANDA 203608 on May 11, 2017, expanding its generic drug portfolio and positioning the company to capture market share in an additional therapeutic category. The approval enables Sagent to offer a competitively priced alternative to branded competitors, potentially driving down costs for patients and payers while contributing to the company's revenue growth in the generic pharmaceuticals segment.